US equities
|
SPCX
$167.00
▲+5.06%
NVDA
$237.02
▲+1.31%
MU
$1,064.26
▼-0.99%
TSLA
$378.23
▲+2.06%
MSFT
$526.26
▲+1.69%
SNDK
$1,715.69
▼-0.25%
INTC
$116.68
▼-2.22%
META
$745.91
▲+2.45%
SPCX
$167.00
▲+5.06%
NVDA
$237.02
▲+1.31%
MU
$1,064.26
▼-0.99%
TSLA
$378.23
▲+2.06%
MSFT
$526.26
▲+1.69%
SNDK
$1,715.69
▼-0.25%
INTC
$116.68
▼-2.22%
META
$745.91
▲+2.45%
FinancialContent
Sign in
Markets
Overview
News
World markets
Treasuries
Currencies
Commodities
Economy
Stocks
Overview
Most active
Gainers
Losers
Largest companies
52-week gainers
52-week losers
ETFs
Overview
Popular funds
Most active
Gainers
Losers
News
Research
Search
Sectors
(OP:
LSBWF
)
0.0061
UNCHANGED
Last Price
Updated: 10:19 AM EDT, Jul 6, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about LSBWF
LakeShore Biopharma Announces Completion of Going Private Transaction
June 24, 2026
BEIJING - June 24, 2026 (NEWMEDIAWIRE) - LakeShore Biopharma Co., Ltd (“LakeShore Biopharma” or the “Company”) (OTCPK: LSBCF; OTCPK: LSBWF), a global biopharmaceutical company dedicated to discovering,...
Via
TheNewswire.com
LakeShore Biopharma Announces Completion of Going Private Transaction
June 24, 2026
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Via
NewMediaWire
LakeShore Biopharma Announces Shareholders' Approval of Merger Agreement
June 19, 2026
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Via
NewMediaWire
LakeShore Biopharma Announces Shareholders' Approval of Merger Agreement
June 19, 2026
BEIJING, CHINA - June 19, 2026 (NEWMEDIAWIRE) - LakeShore Biopharma Co., Ltd (“LakeShore Biopharma” or the “Company”) (OTCPK: LSBCF; OTCPK: LSBWF), a global biopharmaceutical company dedicated to...
Via
TheNewswire.com
LakeShore Biopharma to Hold Extraordinary General Meeting of Shareholders
May 28, 2026
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Via
NewMediaWire
LakeShore Biopharma to Hold Extraordinary General Meeting of Shareholders
May 28, 2026
BEIJING - May 28, 2026 (NEWMEDIAWIRE) - LakeShore Biopharma Co., Ltd (“LakeShore Biopharma” or the “Company”) (OTCPK: LSBCF; OTCPK: LSBWF), a global biopharmaceutical company dedicated to discovering,...
Via
TheNewswire.com
LakeShore Biopharma Enters Into Amended Merger Agreement for Going-Private Transaction
April 29, 2026
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Via
NewMediaWire
LakeShore Biopharma Enters Into Amended Merger Agreement for Going-Private Transaction
April 29, 2026
BEIJING - April 29, 2026 (NEWMEDIAWIRE) - LakeShore Biopharma Co., Ltd (“LakeShore Biopharma” or the “Company”) (OTCPK: LSBCF; OTCPK: LSBWF), a global biopharmaceutical company dedicated to...
Via
TheNewswire.com
